THC Therapeutics, Inc. Quarterly Debt-to-equity in % from Q4 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
THC Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q4 2012 to Q4 2023.
  • THC Therapeutics, Inc. Debt-to-equity for the quarter ending January 31, 2024 was -97.5 %, a 3.14% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 -97.5 +3.16 +3.14% Jan 31, 2024
Q3 2023 -97.5 +4.42 +4.34% Oct 31, 2023
Q2 2023 -98.1 +6.07 +5.83% Jul 31, 2023
Q1 2023 -99.3 +7.2 +6.76% Apr 30, 2023
Q4 2022 -101 +8.32 +7.64% Jan 31, 2023
Q3 2022 -102 +9.57 +8.59% Oct 31, 2022
Q2 2022 -104 +6.73 +6.07% Jul 31, 2022
Q1 2022 -107 +1.33 +1.23% Apr 30, 2022
Q4 2021 -109 -1.59 -1.48% Jan 31, 2022
Q3 2021 -111 -3.23 -2.99% Oct 31, 2021
Q2 2021 -111 +4.53 +3.93% Jul 31, 2021
Q1 2021 -108 -1.8 -1.7% Apr 30, 2021
Q4 2020 -107 -2.4 -2.29% Jan 31, 2021
Q3 2020 -108 -5.88 -5.75% Oct 31, 2020
Q2 2020 -115 +78.9 +40.6% Jul 31, 2020
Q1 2020 -106 -388 -138% Apr 30, 2020
Q4 2019 -105 Jan 31, 2020
Q3 2019 -102 Oct 31, 2019
Q2 2019 -194 Jul 31, 2019
Q1 2019 282 Apr 30, 2019
Q1 2014 -404 -662 -257% Apr 30, 2014
Q4 2013 -43K -43.2K -18248% Jan 31, 2014
Q3 2013 536 Oct 31, 2013
Q2 2013 292 Jul 31, 2013
Q1 2013 258 Apr 30, 2013
Q4 2012 237 Jan 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.